Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 July 2009, doi:10.1136/bmj.b2759
Cite this as: BMJ 2009;339:b2759
Scientific disputes should take place in the pages of journals, not in court
| The first 150 words of the full text of this article appear below. |
Clinicians know they face multiple jeopardy—patients may seek compensation for alleged negligent acts and employers may invoke disciplinary procedures, incidentally with many safeguards for doctors working in the UK NHS recently swept away.1 They may be criticised by coroners, face criminal charges including manslaughter,2 and be subject to sanctions by regulatory bodies. Researchers uninvolved in direct patient care may have felt largely immune to such curbs on their activities, but they are increasingly being exposed to the risk of legal action by disgruntled manufacturers or interest groups.
The United Kingdom has the unenviable reputation of being a haven for those wishing to pursue claims for defamation.3 Peter Wilmshurst, a cardiologist in Shrewsbury, England, is having to defend such an action by NMT Medical, sponsor of the Migraine Intervention with STARflex Technology (MIST) I trial.4 5 Wilmshurst was an investigator in this study into the link between migraine and patent foramen ovale,
Harvey Marcovitch, editor in chief
1 Clinical Risk, Royal Society of Medicine Press Ltd, London W1G 0AE
h.marcovitch@btinternet.com
Read all Rapid Responses